"Designing Growth Strategies is in our DNA"

Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases (Hepatitis, Influenza, Rotavirus) and Bacterial Diseases (Meningococcal Disease), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies) and Region Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI101769

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launch
    2. Pipeline Analysis
    3. Technological Advancements in the Vaccines Market
    4. Prevalence of Disease Indications
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Vaccines Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    5. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    7. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Vaccines Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    3. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    5. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Vaccines Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    3. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    5. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Vaccines Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    3. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    5. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Vaccines Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    3. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    5. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Vaccines Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    3. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    4. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    5. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. GlaxoSmithKline plc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Pfizer Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Merck & Co., Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Novartis AG
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Emergent BioSolutions, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. CSL Limited
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Inovio Pharmaceuticals, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Bavarian Nordic
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Mitsubishi Tanabe Pharma Corporation.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Other Prominent Players
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations

List of Tables

Table 1:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 2:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 3:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2026

Table 4:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Viral Diseases, 2015–2026

Table 5:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Bacterial Diseases, 2015–2026

Table 6:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Age Group, 2015–2026

Table 7:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 8:  Global Vaccines Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 9:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 10:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 11:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 12:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Viral Diseases, 2015-2026

Table 13:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Bacterial Diseases, 2015-2026

Table 14:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Age Group, 2015-2026

Table 15:  North America Vaccines Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  North America Vaccines Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 17:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 18:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 20:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Viral Diseases, 2015-2026

Table 21:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Bacterial Diseases, 2015-2026

Table 22:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Age Group, 2015-2026

Table 23:  Europe Vaccines Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Europe Vaccines Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 25:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 26:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 27:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 28:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Viral Diseases, 2015-2026

Table 29:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Bacterial Diseases, 2015-2028

Table 30:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Age Group, 2015-2026

Table 31:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 32:  Asia Pacific Vaccines Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 33:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 34:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 35:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 36:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Viral Diseases, 2015-2026

Table 37:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Bacterial Diseases, 2015-2026

Table 38:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Age Group, 2015-2026

Table 39:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 40:  Latin America Vaccines Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 41:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 42:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 43:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 44:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Viral Diseases, 2015-2026

Table 45:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Bacterial Diseases, 2015-2026

Table 46:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Age Group, 2015-2026

Table 47:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 48:  Middle East & Africa Vaccines Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

List of Figures

Figure 1:  Global Vaccines Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Vaccines Market Value Share (%), by Type, 2018 & 2026

Figure 3:  Global Vaccines Market Forecast (US$ Mn), by Recombinant/Conjugate/Subunit, 2015-2026

Figure 4:  Global Vaccines Market Forecast (US$ Mn), by Inactivated, 2015-2026

Figure 5:  Global Vaccines Market Forecast (US$ Mn), by Live Attenuated, 2015-2026

Figure 6:  Global Vaccines Market Forecast (US$ Mn), by Toxoid, 2015-2026

Figure 7:  Global Vaccines Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 8:  Global Vaccines Market Forecast (US$ Mn), by Parenteral, 2015-2026

Figure 9:  Global Vaccines Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 10:  Global Vaccines Market Value Share (%), by Disease Indication, 2018 & 2026

Figure 11:  Global Vaccines Market Forecast (US$ Mn), by Viral Diseases, 2015-2026

Figure 12:  Global Vaccines Market Forecast (US$ Mn), by Bacterial Diseases, 2015-2026

Figure 13:  Global Vaccines Market Value Share (%), by Age Group, 2018 & 2026

Figure 14:  Global Vaccines Market Forecast (US$ Mn), by Pediatric, 2015-2026

Figure 15:  Global Vaccines Market Forecast (US$ Mn), by Adults, 2015-2026

Figure 16:  Global Vaccines Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 17:  Global Vaccines Market Forecast (US$ Mn), by Hospital & Retail Pharmacies, 2015-2026

Figure 18:  Global Vaccines Market Forecast (US$ Mn), by Government Suppliers, 2015-2026

Figure 19:  Global Vaccines Market Forecast (US$ Mn), by Others, 2015-2026

Figure 20:  Global Vaccines Market Value (US$ Mn), by Region, 2018 & 2026

Figure 21:  North America Vaccines Market Value (US$ Mn), by Type, 2018 & 2026

Figure 22:  North America Vaccines Market Value Share (%), by Type, 2018

Figure 23:  North America Vaccines Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 24:  North America Vaccines Market Value Share (%), by Route of Administration, 2018

Figure 25:  North America Vaccines Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 26:  North America Vaccines Market Value Share (%), by Disease Indication, 2018

Figure 27:  North America Vaccines Market Value (US$ Mn), by Age Group, 2018 & 2026

Figure 28:  North America Vaccines Market Value Share (%), by Age Group, 2018

Figure 29:  North America Vaccines Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 30:  North America Vaccines Market Value Share (%), by Distribution Channel, 2018

Figure 31:  North America Vaccines Market Value (US$ Mn), By Country, 2018 & 2026

Figure 32:  North America Vaccines Market Value Share (%), By Country, 2018

Figure 33:  Europe Vaccines Market Value (US$ Mn), by Type, 2018 & 2026

Figure 34:  Europe Vaccines Market Value Share (%), by Type, 2018

Figure 35:  Europe Vaccines Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 36:  Europe Vaccines Market Value Share (%), by Route of Administration, 2018

Figure 37:  Europe Vaccines Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 38:  Europe Vaccines Market Value Share (%), by Disease Indication, 2018

Figure 39:  Europe Vaccines Market Value (US$ Mn), by Age Group, 2018 & 2026

Figure 40:  Europe Vaccines Market Value Share (%), by Age Group, 2018

Figure 41:  Europe Vaccines Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 42:  Europe Vaccines Market Value Share (%), by Distribution Channel, 2018

Figure 43:  Europe Vaccines Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 44:  Europe Vaccines Market Value Share (%), By Country/ Sub-region, 2018

Figure 45:  Asia Pacific Vaccines Market Value (US$ Mn), by Type, 2018 & 2026

Figure 46:  Asia Pacific Vaccines Market Value Share (%), by Type, 2018

Figure 47:  Asia Pacific Vaccines Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 48:  Asia Pacific Vaccines Market Value Share (%), by Route of Administration, 2018

Figure 49:  Asia Pacific Vaccines Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 50:  Asia Pacific Vaccines Market Value Share (%), by Disease Indication, 2018

Figure 51:  Asia Pacific Vaccines Market Value (US$ Mn), by Age Group, 2018 & 2026

Figure 52:  Asia Pacific Vaccines Market Value Share (%), by Age Group, 2018

Figure 53:  Asia Pacific Vaccines Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 54:  Asia Pacific Vaccines Market Value Share (%), by Distribution Channel, 2018

Figure 55:  Asia Pacific Vaccines Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 56:  Asia Pacific Vaccines Market Value Share (%), By Country/ Sub-region, 2018

Figure 57:  Latin America Vaccines Market Value (US$ Mn), by Type, 2018 & 2026

Figure 58:  Latin America Vaccines Market Value Share (%), by Type, 2018

Figure 59:  Latin America Vaccines Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 60:  Latin America Vaccines Market Value Share (%), by Route of Administration, 2018

Figure 61:  Latin America Vaccines Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 62:  Latin America Vaccines Market Value Share (%), by Disease Indication, 2018

Figure 63:  Latin America Vaccines Market Value (US$ Mn), by Age Group, 2018 & 2026

Figure 64:  Latin America Vaccines Market Value Share (%), by Age Group, 2018

Figure 65:  Latin America Vaccines Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 66:  Latin America Vaccines Market Value Share (%), by Distribution Channel, 2018

Figure 67:  Latin America Vaccines Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 68:  Latin America Vaccines Market Value Share (%), By Country/ Sub-region, 2018

Figure 69:  Middle East & Africa Vaccines Market Value (US$ Mn), by Type, 2018 & 2026

Figure 70:  Middle East & Africa Vaccines Market Value Share (%), by Type, 2018

Figure 71:  Middle East & Africa Vaccines Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 72:  Middle East & Africa Vaccines Market Value Share (%), by Route of Administration, 2018

Figure 73:  Middle East & Africa Vaccines Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 74:  Middle East & Africa Vaccines Market Value Share (%), by Disease Indication, 2018

Figure 75:  Middle East & Africa Vaccines Market Value (US$ Mn), by Age Group, 2018 & 2026

Figure 76:  Middle East & Africa Vaccines Market Value Share (%), by Age Group, 2018

Figure 77:  Middle East & Africa Vaccines Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 78:  Middle East & Africa Vaccines Market Value Share (%), by Distribution Channel, 2018

Figure 79:  Middle East & Africa Vaccines Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 80:  Middle East & Africa Vaccines Market Value Share (%), By Country/ Sub-region, 2018

Figure 81:  Global Vaccines Market Share (%), By Company, 2018

 class=
  • Jul, 2020
  • 2019
  • 2016-2018
  • 156

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X